Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation

Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating and preventing intestinal injury related to hemorrhagic shock and resuscitation

US Patent 9060977 · Granted Jun 23, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prebiotic formulations for prevention of sepsis and necroenterocolitis induced n2025
Tissue engineered intestine2025
Prebiotic formulations2022
Probiotic formulations and methods for use2022
Prebiotic formulations2020
Probiotic formulations and methods for use2019
Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating 2012
Heparin binding epidermal growth factor (HB-EGF) for use in methods of treating 2012
Methods of treating intestinal ischemia using heparin-binding epidermal growth f2007
Methods of treating intestinal ischemia using heparin-binding epidermal growth f2002
Heparin binding mitogen with homology to epidermal growth factor (EGF)2001
Methods of treating intestinal ischemia using heparin-binding epidermal growth f2001